Pathogenesis of malaria

Parasitology Today

Volumn 16, Issue 10, 2000, Pages 451-454

  Clark, I A ^a   Schofield, L ^b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN F(AB) FRAGMENT; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; VARIANT SURFACE GLYCOPROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

HOST PARASITE INTERACTION; HUMAN; MALARIA; MALARIA FALCIPARUM; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PLASMODIUM FALCIPARUM; REVIEW;

EID: 0034307494     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(00)01757-9     Document Type: Review

References (42)

1. Taylor T.E.et al. Acid-base status in paediatric Plasmodium falciparum malaria. Q. J. Med. 86:1993;99-109.
2. Marsh K.et al. The pathogenesis of severe malaria in African children. Ann. Trop. Med. Parasitol. 90:1996;395-402.
3. English M.et al. Chronic salicylate poisoning and severe malaria. Lancet. 347:1996;1736-1737.
4. Yip L.et al. Salicylate toxicity. J. Intensive Care Med. 12:1997;66-78.
5. Leatherman J.W., Schmitz P.G. Fever, hyperdynamic shock, and multiple-system organ failure. A pseudo-sepsis syndrome associated with chronic salicylate intoxication. Chest. 100:1991;1391-1396.
6. Chalasani N.et al. Systemic inflammatory response syndrome caused by chronic salicylate intoxication. South. Med. J. 89:1996;479-482.
7. Maegraith B. Pathological Processes in Malaria and Blackwater Fever. 1948;Blackwell.
8. Clark I.A.et al. Possible importance of macrophage-derived mediators in acute malaria. Infect. Immun. 32:1981;1058-1066.
9. Spriggs D.R.et al. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase 1 and pharmacologic study. J. Natl. Cancer Inst. 80:1988;1039-1044.
10. Grau G.E.et al. Tumor necrosis factor and disease severity in children with falciparum malaria. New Engl. J. Med. 320:1989;1586-1591.
11. Kwiatkowski D.et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 336:1990;1201-1204.
12. Butcher G.A.et al. Serum TNF associated with malaria in patients in the Solomon Islands. Trans. R. Soc. Trop. Med. Hyg. 85:1990;658-661.
13. Kern P.et al. Elevated tumour necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am. J. Med. 87:1989;139-143.
14. Ho M.et al. Endogenous interleukin-10 modulates proinflammatory response in plasmodium falciparum malaria. J. Infect. Dis. 178:1998;520-525.
15. Day N.et al. The prognostic and pathophysiologic role of pro- and anti-inflammatory cytokines in severe malaria. J. Infect. Dis. 180:1999;1288-1297.
16. Matsumoto J.et al. Malaria infection induces rapid elevation of the soluble fas ligand level in serum and subsequent T lymphocytopenia. possible factors responsible for the differences in susceptibility of two species of Macaca monkeys to Plasmodium coatneyi infection Infect. Immun. 68:2000;1183-1188.
17. Looareesuwan S.et al. Polyclonal anti-tumor necrosis factor-alpha Fab used as an ancillary treatment for severe malaria. Am. J. Trop. Med. Hyg. 61:1999;26-33.
18. Clark I.A.et al. Proposed link between cytokines, nitric oxide, and human cerebral malaria. Parasitol. Today. 7:1991;205-207.
19. Clark I.A.et al. Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet. 340:1992;894-896.
20. Rockett K.A.et al. Possible role of nitric oxide in malarial immunosuppression. Parasite Immunol. 16:1994;243-249.
21. Hirunpetcharat C.et al. Malaria parasite-specific Th1-like T cells simultaneously reduce parasitemia and promote disease. Parasite Immunol. 21:1999;319-329.
22. Kirkeboen K.A., Strand O.A. The role of nitric oxide in sepsis- an overview. Acta Anaesthesiol. Scand. 43:1999;275-288.
23. Clark I.A., Rockett K.A. The cytokine theory of human cerebral malaria. Parasitol. Today. 10:1994;410-412.
24. Clark I.A., Cowden W.B. Why is the pathology of falciparum worse than that of vivax malaria? Parasitol. Today. 15:1999;458-461.
25. Kubata B.K.et al. Plasmodium falciparum produces prostaglandins that are pyrogenic, somnogenic, and immunosuppressive substances in humans. J. Exp. Med. 188:1998;1197-1202.
26. Golgi C. Sull' infezione malarica. Arch. Sci. Med. (Torino). 10:1886;109-135.
27. Maegraith B. The pathogenesis of mammalian malaria. Adv. Parasitol. 10:1972;49-75.
28. Schofield L., Hackett F. Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J. Exp. Med. 177:1993;145-153.
29. Tachado S.D., Schofield L. Glycosylphosphatidylinositol toxin of Trypanosoma brucei regulates IL-1α and TNF-α expression in macrophages by protein tyrosine kinase mediated signal transduction. Biochem. Biophys. Res. Commun. 205:1994;984-991.
30. Tachado S.D.et al. Specificity in signal transduction among glycosylphosphatidylinositols of Plasmodium falciparum, Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp. Parasite Immunol. 12:1999;609-617.
31. Tachado S.D.et al. Glycosylphosphatidylinositol toxin of plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway. J. Immunol. 156:1996;1897-1907.
32. Schofield L.et al. Glycosylphosphatidylinositol toxin of Plasmodium upregulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. J. Immunol. 156:1996;1886-1896.
33. Berendt A.R.et al. Intercellular adhesion molecule-1 is an endothelial cell adhesion molecule for Plasmodium falciparum. Nature. 341:1989;57-59.
34. Tachado S.D.et al. Signal transduction in macrophages by glycosyl-phosphatidylinositols of Plasmodium, Trypanosoma and Leishmania: activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol moieties. Proc. Natl. Acad. Sci. U. S. A. 94:1997;4022-4027.
35. Schofield L.et al. Neutralizing monoclonal antibodies to glycosyl-phosphatidylinositol, the dominant TNF-α-inducing toxin of Plasmodium falciparum. prospects for the immunotherapy of severe malaria Ann. Trop. Med. Parasitol. 87:1993;617-626.
36. Magez S.et al. The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors. J. Immunol. 160:1998;1949-1956.
37. Camargo M.M.et al. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J. Immunol. 158:1997;5890-5901.
38. Almeida I.C.et al. Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO J. 19:2000;1476-1485.
39. Gerold P.et al. Glycosylphosphatidylinositols synthesized by asexual erythrocytic stages of the malarial parasite, Plasmodium falciparum. Candidates for plasmodial glycosylphosphatidylinositol membrane anchor precursors and pathogenicity factors. J. Biol. Chem. 269:1994;2597-2606.
40. Gerold P.et al. Structural analysis of the glycosyl-phosphatidylinositol membrane anchor of the merozoite surface proteins-1 and-2 of Plasmodium falciparum. Mol. Biochem. Parasitol. 75:1996;131-143.
41. Berhe S.et al. Conservation of structure among glycosylphosphatidylinositol toxins from different geographic isolates of Plasmodium falciparum. Mol. Biochem. Parasitol. 103:1999;273-278.
42. Gowda D.C.et al. Glycosylphosphatidylinositol anchors represent the major carbohydrate modification in proteins of intraerythrocytic stage Plasmodium falciparum. J. Biol. Chem. 272:1997;6428-6439.